Conference Coverage

Prostate Cancer in the Elderly

Wayne B. Harris, MD, discusses prostate cancer screening in older patients, including therapeutic objectives, age-related considerations, and active surveillance.


 

References

Concern among the medical community exists regarding risks and benefits of prostate cancer screening in patients aged ≥ 65 years. The clear objective of early detection is usually to prolong life and independence and improve quality of life. This involves a comprehensive risk assessment to be conducted as well as educating the patient about prostate cancer before incorporating their feelings into treatment decisions.

“Even though, quite frequently, men 65 and older are being screened for prostate cancer,” noted Wayne B. Harris, MD, “it is quite infrequent that they are actually diagnosed or treated for prostate cancer.” Dr. Harris also noted that 2 of 3 veterans aged ≥ 65 years who undergo PSA screening will never have a prostate biopsy or receive treatment for prostate cancer.

Recommended Reading

Palliative Radiotherapy for the Management of Metastatic Cancer
AVAHO
Prostate Cancer in Seniors, Part 1: Epidemiology, Pathology, and Screening
AVAHO
Multidisciplinary Treatment of Esophageal Cancer
AVAHO
Update on Advanced Prostate Cancer
AVAHO
AVAHO Readies for 2015 Meeting in Washington
AVAHO
Should Geographic Location Impact Cancer Treatment?
AVAHO
Joao Ascensao Talks AVAHO 2015
AVAHO
Systems Automation for Cancer Surveillance
AVAHO
Major Cancer Death Rates Are Down
AVAHO
Benefits vs Risks of Cancer Screening
AVAHO